Head-To-Head Analysis: Health In Tech (HIT) & Its Peers

Health In Tech (NASDAQ:HIT) is one of 96 publicly-traded companies in the “Healthcare Technology” industry, but how does it weigh in compared to its competitors? We will compare Health In Tech to related businesses based on the strength of its institutional ownership, earnings, dividends, valuation, profitability, analyst recommendations and risk.

Valuation and Earnings

This table compares Health In Tech and its competitors gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Health In Tech	$32.83 million	N/A	-14.29
Health In Tech Competitors	$339.33 million	-$23.71 million	13.22

Health In Tech’s competitors have higher revenue, but lower earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Health In Tech and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Health In Tech Competitors	-768.38%	-39.52%	-18.03%

Institutional and Insider Ownership

41.7% of shares of all “Healthcare Technology” companies are held by institutional investors. 77.7% of Health In Tech shares are held by company insiders. Comparatively, 15.9% of shares of all “Healthcare Technology” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current recommendations and price targets for Health In Tech and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1	0	1	1	2.67
Health In Tech Competitors	431	1491	2722	87	2.52

Health In Tech currently has a consensus price target of $3.50, indicating a potential upside of 249.93%. As a group, “Healthcare Technology” companies have a potential upside of 46.70%. Given Health In Tech’s stronger consensus rating and higher possible upside, equities analysts clearly believe Health In Tech is more favorable than its competitors.

Risk & Volatility

Health In Tech has a beta of 2.82, suggesting that its share price is 182% more volatile than the S&P 500. Comparatively, Health In Tech’s competitors have a beta of 1.12, suggesting that their average share price is 12% more volatile than the S&P 500.

Summary

Health In Tech beats its competitors on 8 of the 12 factors compared.

Health In Tech Company Profile

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.